More details on this developing story will follow.
Baird raises Climb Bio stock price target to $25 on trial data
By Dhallo News · September 3, 2026 at 10:33 PM IST
SOURCE: Investing.com - News
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion
